Equity Management & Valuation, Ascenion GmbH
Anja has worked for Ascenion GmbH since September 2001. She is responsible for managing the equity of Ascenion’s Spin offs, for scientific and economic evaluations of inventions and for promoting licenses of Intellectual Property Rights to the biotech industry and big pharma. Apart from analysing the scientific background of inventions, she also assesses the market potential of Intellectual property. This ranges from general market reviews to detailed analysis, including net present value (NPV) calculations. She is also responsible for the commercialisation of mouse models of the Mouse Genetics Cologne foundation for biomedical research.
She joined ASTP's Professional Development Committee in 2011, volunteering there until becoming a Board member in 2021.
Prior to joining Ascenion, Anja worked at Klinikum Grosshadern, Munich and at Mount Sinai School of Medicine, New York in cancer research. She studied biology and did her PhD work at the Ludwig-Maximilians-University in Munich, focusing on immunology, microbiology and molecular biology and received her MBA from Cardiff University. Before going to university she was worked for Deutsche Bank AG.
Anja is an expert for the European Commission, evaluator and jury member for HTGF, BayStartUP, the Vienna business agency, member of supervisory and advisory boards of various biotech companies and chairperson of the MGC foundation.